Neurology · 2004 · 68 citations · 9 references
Life SciencesImmunologyNeurologyAutoimmunityImmunopathologyNeuroimmunologyAntibody CharacterizationDemyelinating DiseasesDemyelinating DisordersMultiple SclerosisOligodendrocyte BiologyBiomarker DetectionMog Antibody DiseaseMultiple Sclerosis ImmunopathogenesisMultiple Sclerosis ImmunopathologyMultiple Sclerosis PathologyMyelin AntigensMyelin-associated GlycoproteinNeuroinflammation In Multiple Sclerosis
Antibodies against native glycosylated myelin-oligodendrocyte-glycoprotein (MOG) were measured by ELISA in patients with multiple sclerosis (MS) and controls. Anti-MOG IgM antibodies were elevated during the first demyelinating event. Higher MOG-specific IgG antibodies were found in patients during relapses and in secondary chronic progressive MS compared to patients in remission and healthy controls. Antibodies against native MOG may be a potential biomarker for MS.
9
Christopher Linington, Hans Lassmann · Journal of Neuroimmunology · 1987 · 219 citations
Life Sciences, Immunology, Neurology +17
Similar low frequency of anti-MOG IgG and IgM in MS patients and healthy subjects
Vito Lampasona, Diego Franciotta, Roberto Furlan et al. · Neurology · 2004 · 149 citations
Life Sciences, Immunology, Neurology +15